机构：[1]State Key Laboratory of Biotherapy, Collaborative Innovation Center of Biotherapy and Cancer Center,West China Hospital of Sichuan University, Chengdu, 610041, China 四川大学华西医院[2] Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Ministry of Education & State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550004, Guizhou, China [3]College of Pharmacy, Xinxiang Medical University, Xinxiang, Henan, 453003, China [4] Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu, 610052, China
National Natural Science Foundation of China (grants 81773195 and 81472780).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2019]版：
大类|1 区医学
小类|1 区药物化学
最新[2023]版：
大类|2 区医学
小类|1 区药物化学
第一作者：
第一作者机构：[1]State Key Laboratory of Biotherapy, Collaborative Innovation Center of Biotherapy and Cancer Center,West China Hospital of Sichuan University, Chengdu, 610041, China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Yan Guoyi,Pu Chunlan,Lan Suke,et al.Discovery of 4-phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as potent and orally active PI3K/mTOR dual inhibitors.[J].European journal of medicinal chemistry.2019,178:667-686.doi:10.1016/j.ejmech.2019.06.021.
APA：
Yan Guoyi,Pu Chunlan,Lan Suke,Zhong Xinxin,Zhou Meng...&Li Rui.(2019).Discovery of 4-phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as potent and orally active PI3K/mTOR dual inhibitors..European journal of medicinal chemistry,178,
MLA：
Yan Guoyi,et al."Discovery of 4-phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as potent and orally active PI3K/mTOR dual inhibitors.".European journal of medicinal chemistry 178.(2019):667-686
医学